HealthWatchlist verdict: Essential oils are not established replacements for psoriasis treatment. A few human formulation studies exist, but their ingredients and comparison groups matter, and newer mouse experiments do not demonstrate human benefit.
Understanding the condition
Psoriasis is an inflammatory skin condition that can cause persistent scaly patches and nail changes. It is not a sign of poor hygiene or something that can simply be disinfected away. Some people also develop joint symptoms.
Skin comfort, plaque severity, quality of life and control of joint disease are separate outcomes. A product that makes skin feel less dry has not necessarily changed the disease process.
The evidence in context
| Preparation | Evidence to consider | What remains uncertain |
|---|---|---|
| Kunzea oil added to an active topical base | A small randomised trial found no significant added benefit. | It does not support the oil as an effective additional treatment. |
| Chamomile-pumpkin oleogel | A small study reported improvement in treated plaques. | It used a traditional chamomile extract in oil, not bottled chamomile essential oil alone. |
| Frankincense-containing herbal cream | A combination study reported benefits. | Several ingredients prevent attribution to frankincense alone. |
| Tea tree, patchouli or Artemisia delivery systems | Recent experiments include mouse models. | Human effectiveness and safety are not established by those experiments. |
An important negative trial
The kunzea-oil trial included 30 people and compared formulations with and without the oil for eight weeks. Both groups received coal-tar solution and salicylic acid in the treatment base. Both improved, without a statistically significant difference between them.
Reporting only that participants improved would miss the main finding: adding kunzea oil did not demonstrate extra benefit over that active base. A control group is what allows an improvement to be interpreted.
Chamomile and frankincense formulations
The chamomile-pumpkin study compared matched plaques within 40 participants over four weeks, with 37 completing the study. The preparation performed better on plaque measures. However, its chamomile component was made from a water extract processed into sesame oil. That is not the same substance as steam-distilled chamomile essential oil.
A frankincense-containing cream trial is also relevant, but the formulation combined frankincense material with pumpkin oil and liquorice extract. The 2024 scoping review describes its positive findings and the limitations of the broader evidence. A combination result cannot tell us which component produced the effect.
These studies should neither be omitted nor turned into endorsements for unrelated bottles. Product identity is part of the evidence, not a minor detail that can be dropped from a summary.
What newer research adds
Artemisia nanoformulations were tested in mice with experimentally induced psoriasis-like skin changes. A tea-tree-releasing experimental dressing and a patchouli microemulsion gel also have preclinical findings. Their delivery materials are part of the intervention.
Reduced inflammation in a mouse model is useful for development, but it does not establish symptom control in people or tell a reader how to make a safe substitute. The word “psoriasis” in a paper title is not enough to make it a human treatment trial.
A systematic review of complementary psoriasis approaches covers several unrelated interventions, including non-oil preparations. Its results cannot be assigned wholesale to essential oils.
Care and safety
NHS guidance describes moisturisers, prescribed topical treatments and specialist options according to severity. Persistent symptoms or troublesome adverse effects are reasons to review treatment with a clinician. Replacing a working treatment with an oil may leave inflammation uncontrolled.
Fragranced essential oils can themselves cause dermatitis. A new itchy rash after adding a product may reflect irritation or allergy. Avoid applying concentrated oils to cracked or inflamed skin, and do not combine products with prescribed light treatment without checking with the treating team.
New recurring joint pain, swelling or stiffness deserves medical assessment. Rapidly worsening widespread skin changes, pus-filled lesions or feeling acutely unwell require urgent care. These are not situations in which to test another topical blend.
Overall conclusion
The strongest reason for caution is the gap between the studied products and the claims made for ordinary essential oils. The negative kunzea comparison and the mixed formulations deserve as much attention as encouraging laboratory results.
For now, the evidence supports further product-specific research. It does not establish a reliable essential-oil treatment for psoriasis or its joint complications.
How this review was researched
Research checked on 12 September 2026. We searched PubMed using the oil or preparation name and the condition, checked relevant reviews and their cited trials, and consulted the official guidance linked below. This is an editorial review, not an exhaustive systematic review. Laboratory findings, combination products and uncontrolled reports are distinguished from controlled evidence for the exact claim.
Related reading
- Eczema is a different skin condition
- German chamomile and preparation differences
- Frankincense oil profile
- Essential oil safety
References
- Safety and efficacy of kunzea oil-containing formulations for the management of psoriasis: a randomized, controlled trial.
- Kolahdooz et al. (2018): Chamomile-pumpkin oleogel trial
- Fadaei et al. (2022): Frankincense-containing combination cream trial
- The Therapeutic Potential of Essential Oils in Managing Inflammatory Skin Conditions: A Scoping Review.
- Artemisia monosperma essential oil nanoformulations alleviate imiquimod-induced psoriasis-like dermatitis in mice.
- A Collagen Pickering Emulsion-Coated Mycelium Film with Hydro-Responsive Toughness and Adhesion for Psoriasis Treatment via Tea Tree Oil Release.
- Patchouli oil microemulsion-in-gel system for topical treatment of psoriasis.
- Complementary and Alternative Medicine Therapies for Psoriasis: A Systematic Review.
- NHS: Psoriasis
- DermNet: Allergic contact dermatitis to essential oils
Read favourable turmeric trials alongside the limitations
Evidence update: 13 September 2026.
A small scalp-psoriasis tonic trial reported benefit, while an earlier oral-curcumin pilot had a low response rate. These different formulations cannot be pooled informally into a claim that essential oil works. A 2022 review included seven clinical randomised trials and 19 preclinical studies, not 26 human trials.
Related evidence review: Turmeric Oil for Psoriasis: Why Curcumin Trials Do Not Prove the Oil Works.
Include the negative coconut phototherapy result
Evidence update: 14 September 2026.
A controlled half-body study found no faster psoriasis clearance from coconut oil applied before PUVA or narrow-band UVB. A dry-skin trial supports moisturising effects, but cannot establish psoriasis control. Ask the phototherapy team which products to use before treatment rather than adding oils independently.
Related evidence review: Coconut Oil for Psoriasis: Moisturising Evidence and the Phototherapy Trial.